待处理
入排:排除
图源:待检查
Response to: 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang.
James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi
Ann Rheum Dis 82(7) e169
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板